Medline Inc. (MDLN) vs ResMed Inc. (RMD)

Medline Inc. and ResMed Inc. are both Medical Instruments & Supplies companies. Medline Inc. is the larger, with a market value of $45.5B against $31.9B — 1.4× the size. ResMed Inc. has the higher net margin (26.9% vs 2.37%) and the higher return on invested capital (21.4% vs 19.9%). Across the 16 metrics below, ResMed Inc. leads on 9 and Medline Inc. on 7.

Valuation

Metric MDLN RMD Medical Instruments & Supplies median
P/E — 21.25 34.17
P/S 1.00 5.72 2.83
P/B 1.56 4.91 2.82
Price to free cash flow 12.91 19.86 25.69
EV/EBITDA 3.95 14.68 16.08
EV/Sales 1.33 5.53 3.06
Earnings yield — 4.71% (1.84%)
Free cash flow yield 7.75% 5.03% 0.17%

Profitability

Metric MDLN RMD Medical Instruments & Supplies median
Gross margin 46.27% 61.06% 54.62%
Operating margin 31.12% 33.37% 1.64%
Net margin 2.37% 26.94% 0.00%
Free cash flow margin 7.75% 28.81% 1.61%
Return on equity 0.00% 24.27% 0.00%
Return on assets 3.58% 17.77% 0.00%
Return on invested capital 19.94% 21.38% 0.00%

Growth

Metric MDLN RMD Medical Instruments & Supplies median
Revenue growth (TTM) — 9.85% 9.20%
EPS growth (last fiscal year) — 9.67% —
Revenue growth, 5-year CAGR — 12.08% 9.48%
Net income growth, 5-year CAGR — 26.27% 0.00%

Health

Metric MDLN RMD Medical Instruments & Supplies median
Debt to equity 0.66 0.06 0.08
Current ratio 4.33 3.10 2.49
Net debt to EBITDA 3.24 (0.50) 0.83

Dividend

Metric MDLN RMD Medical Instruments & Supplies median
Dividend yield — 1.06% 0.99%
Payout ratio — 0.29 0.00

Size

Metric MDLN RMD Medical Instruments & Supplies median
Market cap 45.52b 31.91b 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack